GEODE CAPITAL MANAGEMENT, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$564,597
-29.3%
218,778
+18.3%
0.00%
Q2 2023$798,638
+182.4%
184,8700.0%0.00%
Q1 2023$282,851
+96766.8%
184,8700.0%0.00%
Q4 2022$292
-99.9%
184,870
-0.2%
0.00%
Q3 2022$229,000
-35.9%
185,219
+4.6%
0.00%
Q2 2022$357,000
-18.3%
177,022
+1.2%
0.00%
Q1 2022$437,000
-30.1%
174,858
+4.2%
0.00%
Q4 2021$625,000
-7.0%
167,7630.0%0.00%
Q3 2021$672,000
+13.1%
167,763
+25.6%
0.00%
Q2 2021$594,000
-49.4%
133,569
+4.0%
0.00%
Q1 2021$1,175,000
+11.8%
128,468
+23.9%
0.00%
Q4 2020$1,051,000
+296.6%
103,699
+65.5%
0.00%
Q3 2020$265,000
-32.1%
62,662
+11.1%
0.00%
Q2 2020$390,000
+142.2%
56,412
-1.9%
0.00%
Q1 2020$161,000
-5.3%
57,524
+63.8%
0.00%
Q4 2019$170,000
+448.4%
35,114
+128.0%
0.00%
Q3 2019$31,00015,3990.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,146,470$4,861,0005.06%
Corriente Advisors, LLC 730,000$3,095,0001.57%
Manatuck Hill Partners, LLC 571,500$2,423,0001.11%
CVI Holdings, LLC 276,176$1,171,0000.48%
DAFNA Capital Management LLC 156,529$664,0000.22%
Worth Venture Partners, LLC 42,887$182,0000.15%
Granite Point Capital Management, L.P. 646,855$2,743,0000.15%
Ikarian Capital, LLC 415,000$1,759,0000.13%
Maven Securities LTD 359,285$1,473,0000.12%
Nantahala Capital Management 756,193$3,206,0000.10%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders